Drug Trial Radar · NCT05494788
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)
Last checked: Nov 19, 2026Latest source record: Oct 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
27
Actual
Start
Jan 9, 2023
Primary completion
Jun 15, 2024
Study completion Sep 6, 2024
Sponsor
- Lead sponsor
- Cardiol Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 10, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Patients with recurrent pericarditis who are refractory or intolerant to current therapeutic management options or who require long-term administration of corticosteroids to control their disease are particularly challenging to manage. The pathogenesis of pericarditis involves the activation of the inflammasome. CardiolRxTM (a pure cannabidiol \[CBD\] solution) is known to have anti-inflammatory properties, including modulation of inflammasome signaling. This pilot study is to assess the tolerance and safety of CardiolRxTM during the resolution of pericarditis symptoms, assess improvement in objective measures of disease, and during the extension period, assess the feasibility of weaning concomitant background therapy including corticosteroids while taking CardiolRxTM.
Conditions
- Recurrent Pericarditis
Interventions
CardiolRxDrug
Oral solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- 11-point NRS Pain ScoreTime frame: 8 weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Pima Heart and Vascular Clinical Research
Tucson, Arizona
MedStar Health Research Institute
Washington D.C., District of Columbia
Massachusetts General Hospital
Boston, Massachusetts
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Cleveland Clinic
Cleveland, Ohio
University of Vermont Medical Center
Burlington, Vermont
Virginia Commonwealth University Health
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.